[{"AccountsPayableCurrent_0_Q1_USD":10994082.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":180993032.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q1_USD":6800000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q1_USD":106600000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q1_USD":113400000.0,"RestrictedCashCurrent_0_Q1_USD":1400000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":269506000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":141099.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-264609.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":269360926.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":589161.0,"PaymentsToAcquireInvestments_1_Q1_USD":210466633.0,"InvestmentIncomeInterest_1_Q1_USD":1678203.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-273516.0,"OperatingLeaseExpense_1_Q1_USD":818000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-47684118.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1188095880.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":18.95,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3869771.0,"OtherAssetsNoncurrent_0_Q1_USD":86084.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_1_Q1_USD":53533.0,"CostOfGoodsAndServicesSold_1_Q1_USD":69000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":23.94,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":10667765.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":6368661.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":17.86,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.925,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":97234.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1083479.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":57503736.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-273516.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":18051146.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":19718023.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3211234.0,"OperatingLeaseLiability_0_Q1_USD":22900000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"MoneyMarketFundsAtCarryingValue_0_Q1_USD":85000000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":1250025.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":0.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-8740512.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":1000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":73356183.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_0_Q1_Securities":28.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":520000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":505000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":360000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5504297.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":6203283.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":298210.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":7.81,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.916,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":17.86,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1_Q1_shares":656433.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-51226218.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-152984946.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":277567347.0,"LiabilitiesCurrent_0_Q1_USD":31076364.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":481242717.0,"Liabilities_0_Q1_USD":50794387.0,"InventoryNet_0_Q1_USD":1391124.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1562620.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1351013.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":3569058.0,"NetIncomeLoss_1_Q1_USD":-47410602.0,"IncomeTaxExpenseBenefit_1_Q1_USD":3281.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.73,"Depreciation_1_Q1_USD":148802.0,"CommonStockValue_0_Q1_USD":6620.0,"CommonStockSharesOutstanding_0_Q1_shares":55507497.0,"CommonStockSharesIssued_0_Q1_shares":66200761.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":179593032.0,"AssetsCurrent_0_Q1_USD":460972500.0,"Assets_0_Q1_USD":481242717.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-145199.0,"AccountsReceivableNetCurrent_0_Q1_USD":1351013.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-47407321.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":22049.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7876405.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":276978186.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":16.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":115756.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":5790220.0,"IncreaseDecreaseInInventories_1_Q1_USD":1391124.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":3657233.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q1_USD":53533.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":211961.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0142,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":5504297.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":34096366.0,"ResearchAndDevelopmentExpense_1_Q1_USD":16003326.0,"OperatingIncomeLoss_1_Q1_USD":-49085524.0,"OperatingExpenses_1_Q1_USD":50169003.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":65106103.0,"StockholdersEquity_0_Q1_USD":430448330.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-757508971.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2132987.0,"ProfitLoss_1_Q1_USD":-47410602.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":6368661.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":589161.0,"Ticker":"ITCI","CIK":"1567514","name":"INTRA-CELLULAR THERAPIES, INC.","OfficialName":"Intra-Cellular Therapies Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5718578003.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]